ArticleBMJ public health2024
Effect of living in well-insulated warm houses on hypertension and cardiovascular diseases based on a nationwide epidemiological survey in Japan: a modelling and cost-effectiveness analysis.
Article in BMJ public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Japanese Society of Hypertension Practical Consensus Guidelines for Seasonal Blood Pressure Management.Hypertension research : official journal of the Japanese Society of Hypertension · 2026Article
- Research Progress on the Therapeutic Mechanisms of Stigmasterol for Multiple Diseases.Molecules (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Cardiovascular diseases (CVDs) are more prevalent in colder homes, partly due to cold-induced high blood pressure (BP). While thermal insulation and heating are rational strategies to mitigate cold exposure, the high initial and running costs pose significant barriers. Therefore, this study aims to evaluate the cost-effectiveness of living in well-insulated warm houses. Methods: An economic model was developed based on the indoor temperature-BP and BP-CVDs relationships. Five scenarios were outlined: a base scenario (Scenario 0: the most prevalent thermal insulation level (Grade 2) and indoor temperature (15°C) in Japan), two scenarios of upgrading insulation and living in warm houses after age 40 years (Scenario 1-1: Grade 4 & 18°C and Scenario 1-2: Grade 6 & 21°C), and two scenarios of retrofitting insulation of entire houses and living in warm houses after age 60 years (Scenario 2-1: Grade 4 & 18°C and Scenario 2-2: Grade 6 & 21°C). Monte Carlo simulations for 100 000 virtual husband-wife pairs were conducted to investigate quality-adjusted life-years (QALYs) and life-cycle costs for thermal insulation work, heating and medical treatments. Results: Regarding the upgrading insulation scenarios, compared with Scenario 0, Scenarios 1-1 and 1-2 increased the life-cycle cost by Japanese yen (JPY) 0.26 and JPY0.84 million, respectively, while extending the combined healthy life expectancy of a husband and wife by 0.31 and 0.48 QALYs. The incremental cost-effectiveness ratios were below the threshold value of JPY5 million/QALY gained. Regarding the retrofitting insulation scenarios, probabilistic sensitivity analyses showed that Scenario 2-2 emerged as the most cost-effective option when the willingness to pay reached JPY6.5 million or more, which is above the threshold. Conclusions: Upgrading insulation and residing in warmer homes could be cost-effective strategies. When conducting insulation retrofitting, lower-cost methods such as partial insulation retrofitting should be considered. These findings support decision-making for residents and policymakers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.